Results showed that knockdown of BAP18 in LM2-4175 cells decreased xenograft tumor incidence, volume, and weight, and the noted effects were partially reverted by reintroduction of Flag-S100A9 into LM2-4175 cells expressing shBAP18 (Fig. 7B−D, respectively). This evidence concerns the gene S100A9 and neoplasm.